News
Public · Published
Reliance fuels Nifty's best single-day jump in months; Sensex reclaims 75,600
Indian stocks rose for a third straight session on Monday. The Sensex closed at 75,692, while the Nifty50 ended at 23,440.80. Reliance Industries had its strongest single-day gain since April 2020 after better-than-expected second-quarter results, contributing the most to the Nifty's advance.
Published:
Updated:
What happened
Indian stocks rose for a third straight session on Monday. The Sensex closed at 75,692, while the Nifty50 ended at 23,440.80. Reliance Industries had its strongest single-day gain since April 2020 after better-than-expected second-quarter results, contributing the most to the Nifty’s advance.
Confirmed
Global impact / market context
Reliance’s large weight in the Nifty meant its sharp rise lifted the index more than most individual stocks could. Better quarterly results can also support investor expectations for the company’s earnings, while lower crude oil prices may ease cost pressure for energy, metals and auto businesses.
Analyst inference
Lower crude prices can reduce input costs for companies that use oil, while stronger earnings can support share prices by improving profit expectations. Reliance’s large index weight amplified its gain in the Nifty; sustaining the broader recovery may depend on continued institutional inflows and earnings support, as the article notes.
Analyst inference
What to watch
- Watch Reliance’s next reported results for evidence that its second-quarter performance can continue; sustained earnings strength could help support the stock and its contribution to the Nifty. Analyst inference
- Track crude oil prices and company updates for signs that lower input costs are helping metals, energy and auto businesses, rather than providing only temporary relief. Analyst inference
- The article says sustaining the recovery will require continued institutional inflows, softer crude prices and broader earnings support; these are conditions cited by a market analyst. Confirmed
Evidence
- Original source link unavailable